Century Communities vs Everus Construction
CCS and ECG side by side, both in operative builders. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CCS and ECG compare
Everus Construction is the larger company, worth 3.0 times as much as Century Communities ($4.4B against $1.5B).
On earnings, Century Communities is cheaper: it trades at 13.7× trailing earnings, against 15.1× for Everus Construction.
Everus Construction grew revenue faster over the last twelve months (33.5% versus −8.2% for Century Communities).
Everus Construction keeps more of each dollar of sales as profit, with a net margin of 6.2% compared with 2.9% at Century Communities.
Century Communities pays a dividend yielding 2.4%; Everus Construction does not pay one.
Everus Construction scores higher on the StockData Score (17 against 9 for Century Communities), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CCS | ECG |
|---|---|---|
| Size and price | ||
| Market cap | $1.5B | $4.4B |
| Share price | $51.36 | $85.25 |
| Change, 1 year | −14.7% | −14.4% |
| Change, 5 years | −29.6% | – |
| Beta (5Y) | 1.03 | 1.90 |
| Employees | 484 | 10K |
| StockData Score | ||
| Total score | 9 | 17 (better) |
| Valuation score | 2 | 3 (better) |
| Growth score | 1 | 5 (better) |
| Performance score | 0 | 5 (better) |
| Health score | 4 | 4 |
| Dividend score | 2 (better) | 0 |
| Valuation | ||
| P/E | 13.7× (better) | 15.1× |
| P/S | 0.4× (better) | 0.9× |
| P/B | 0.6× (better) | 5.0× |
| EV/EBITDA | 8.2× (better) | 12.2× |
| P/FCF | – | 18.3× |
| PEG | – | 0.87 |
| FCF yield | −6.0% | 5.5% (better) |
| Fair value | $43.33 | $88.29 |
| Margin of safety | −18.5% | 3.4% (better) |
| Growth | ||
| Revenue growth (TTM) | −8.2% | 33.5% (better) |
| Revenue growth, 5Y average | 5.4% | – |
| Net income growth (TTM) | −49.1% | 59.9% (better) |
| EPS growth (TTM) | −45.3% | 60.1% (better) |
| EPS growth, 5Y average | −4.5% | – |
| Profitability | ||
| Gross margin | – | 13.6% |
| Operating margin | – | 8.2% |
| Net margin | 2.9% | 6.2% (better) |
| FCF margin | −2.3% | 5.1% (better) |
| Return on equity | 4.2% | 40.3% (better) |
| Return on invested capital | – | 30.0% |
| Financial health | ||
| Debt / equity | 0.00 | 0.66 (better) |
| Net debt / EBITDA | – | 0.79 |
| Interest coverage | – | 18.7× |
| Current ratio | – | 1.53 |
| Altman Z-score | 1.84 | 4.25 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.4% | – |
| Payout ratio | 32.9% | – |
| Buyback yield | 6.3% | – |
| Shareholder yield | 8.7% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 93.2% | 85.0% |
| Held by insiders | 15.2% | 0.57% |
| Insider net buying, 12 months | −$7.3M | −$283K (better) |
| Short interest, % of float | 8.4% | 4.1% |
Go deeper
- CCS stock overview
- CCS income statement
- CCS valuation and score
- ECG stock overview
- ECG income statement
- ECG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.